{"id":"https://openalex.org/W2107942125","doi":"https://doi.org/10.1172/jci30945","title":"Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas","display_name":"Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas","alternate_titles":[],"publication_year":2007,"publication_date":"2007-03-15","ids":{"openalex":"https://openalex.org/W2107942125","doi":"https://doi.org/10.1172/jci30945","mag":"2107942125","pmid":"https://pubmed.ncbi.nlm.nih.gov/17364023","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1810577"},"language":"en","primary_location":{"id":"doi:10.1172/jci30945","doi":"https://doi.org/10.1172/jci30945","is_oa":true,"landing_page_url":"https://doi.org/10.1172/jci30945","pdf_url":"http://www.jci.org/articles/view/30945/files/pdf","source":{"id":"https://openalex.org/S114430552","display_name":"Journal of Clinical Investigation","issn_l":"0021-9738","issn":["0021-9738","1558-8238"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320279","host_organization_name":"American Society for Clinical Investigation","host_organization_lineage":["https://openalex.org/P4310320279"],"host_organization_lineage_names":["American Society for Clinical Investigation"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Investigation","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2107942125"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.jci.org/articles/view/30945/files/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024085151","display_name":"Grzegorz Sarek","orcid":"https://orcid.org/0000-0002-1331-3351","observed_orcids":["https://orcid.org/0000-0002-1331-3351"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Grzegorz Sarek","raw_affiliation_strings":["Genome-Scale Biology Program, Biomedicum Helsinki, Institute of Biomedicine, University of Helsinki, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genome-Scale Biology Program, Biomedicum Helsinki, Institute of Biomedicine, University of Helsinki, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109880874","display_name":"Sari Kurki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sari Kurki","raw_affiliation_strings":["Haartman Institute , University of Helsinki , Helsinki , Finland","Molecular and Cancer Biology Program , Biomedicum Helsinki , Institute of Biomedicine , and","Molecular and Cancer Biology Program, Biomedicum Helsinki, Institute of Biomedicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haartman Institute , University of Helsinki , Helsinki , Finland","institution_ids":["https://openalex.org/I133731052"]},{"raw_affiliation_string":"Molecular and Cancer Biology Program , Biomedicum Helsinki , Institute of Biomedicine , and","institution_ids":[]},{"raw_affiliation_string":"Molecular and Cancer Biology Program, Biomedicum Helsinki, Institute of Biomedicine","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059603239","display_name":"Juulia Enb\u00e4ck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Juulia Enb\u00e4ck","raw_affiliation_strings":["Molecular and Cancer Biology Program , Biomedicum Helsinki , Institute of Biomedicine , and","Molecular and Cancer Biology Program, Biomedicum Helsinki, Institute of Biomedicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular and Cancer Biology Program , Biomedicum Helsinki , Institute of Biomedicine , and","institution_ids":[]},{"raw_affiliation_string":"Molecular and Cancer Biology Program, Biomedicum Helsinki, Institute of Biomedicine","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039979784","display_name":"Guergana Iotzova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405261663","display_name":"Max-von-Pettenkofer-Institut f\u00fcr Hygiene und Medizinische Mikrobiologie","ror":"https://ror.org/05na4hm84","country_code":"DE","type":"education","lineage":["https://openalex.org/I4405261663","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]},{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["DE","GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Guergana Iotzova","raw_affiliation_strings":["Max von Pettenkofer Institut LMU-M\u00fcnchen , Munich , Germany and","Ludwig Maximilian University of Munich","University of Edinburgh"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Max von Pettenkofer Institut LMU-M\u00fcnchen , Munich , Germany and","institution_ids":["https://openalex.org/I4405261663","https://openalex.org/I8204097"]},{"raw_affiliation_string":"Ludwig Maximilian University of Munich","institution_ids":["https://openalex.org/I8204097"]},{"raw_affiliation_string":"University of Edinburgh","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008152480","display_name":"Juergen Haas","orcid":"https://orcid.org/0000-0002-3255-7773","observed_orcids":["https://orcid.org/0000-0002-3255-7773"]},"institutions":[{"id":"https://openalex.org/I4405261663","display_name":"Max-von-Pettenkofer-Institut f\u00fcr Hygiene und Medizinische Mikrobiologie","ror":"https://ror.org/05na4hm84","country_code":"DE","type":"education","lineage":["https://openalex.org/I4405261663","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Juergen Haas","raw_affiliation_strings":["Max von Pettenkofer Institut LMU-M\u00fcnchen , Munich , Germany and","Deanery of Biomedical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Max von Pettenkofer Institut LMU-M\u00fcnchen , Munich , Germany and","institution_ids":["https://openalex.org/I4405261663","https://openalex.org/I8204097"]},{"raw_affiliation_string":"Deanery of Biomedical Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069828504","display_name":"Pirjo Laakkonen","orcid":"https://orcid.org/0000-0002-9620-095X","observed_orcids":["https://orcid.org/0000-0002-9620-095X"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pirjo Laakkonen","raw_affiliation_strings":["Molecular and Cancer Biology Program , Biomedicum Helsinki , Institute of Biomedicine , and","#N##TAB##TAB##TAB##TAB# University of Helsinki#N##TAB##TAB##TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular and Cancer Biology Program , Biomedicum Helsinki , Institute of Biomedicine , and","institution_ids":[]},{"raw_affiliation_string":"#N##TAB##TAB##TAB##TAB# University of Helsinki#N##TAB##TAB##TAB#","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028508240","display_name":"Marikki Laiho","orcid":"https://orcid.org/0000-0002-5625-6430","observed_orcids":["https://orcid.org/0000-0002-5625-6430"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marikki Laiho","raw_affiliation_strings":["#N##TAB##TAB##TAB##TAB# University of Helsinki#N##TAB##TAB##TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"#N##TAB##TAB##TAB##TAB# University of Helsinki#N##TAB##TAB##TAB#","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020347192","display_name":"P\u00e4ivi M. Ojala","orcid":"https://orcid.org/0000-0001-9065-1832","observed_orcids":["https://orcid.org/0000-0001-9065-1832"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"P\u00e4ivi M. Ojala","raw_affiliation_strings":["Department of Biochemistry and Developmental Biology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Developmental Biology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5020347192"],"corresponding_institution_ids":[],"apc_list":{"value":5200,"currency":"USD","value_usd":5200},"apc_paid":null,"fwci":7.2331,"has_fulltext":true,"cited_by_count":155,"citation_normalized_percentile":{"value":0.97848897,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"117","issue":"4","first_page":"1019","last_page":"1028"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.052799999713897705,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kaposi-s-sarcoma-associated-herpesvirus","display_name":"Kaposi's sarcoma-associated herpesvirus","score":0.9549999833106995},{"id":"https://openalex.org/keywords/primary-effusion-lymphoma","display_name":"primary effusion lymphoma","score":0.9909999966621399},{"id":"https://openalex.org/keywords/mdm2-inhibitors","display_name":"MDM2 inhibitors","score":0.871999979019165},{"id":"https://openalex.org/keywords/nutlin-3a","display_name":"Nutlin-3a","score":0.9980000257492065},{"id":"https://openalex.org/keywords/lana","display_name":"LANA","score":0.972000002861023},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9240000247955322},{"id":"https://openalex.org/keywords/dna-damage-signaling","display_name":"DNA damage signaling","score":0.8889999985694885},{"id":"https://openalex.org/keywords/antiviral-therapy","display_name":"antiviral therapy","score":0.7179999947547913},{"id":"https://openalex.org/keywords/kaposi-sarcoma","display_name":"Kaposi's sarcoma","score":0.8690000176429749},{"id":"https://openalex.org/keywords/mouse-xenograft-model","display_name":"xenograft mouse model","score":0.7440000176429749}],"concepts":[{"id":"https://openalex.org/C2779594685","wikidata":"https://www.wikidata.org/wiki/Q3832899","display_name":"Primary effusion lymphoma","level":3,"score":0.9614764451980591},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7231552004814148},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6795737743377686},{"id":"https://openalex.org/C2776192174","wikidata":"https://www.wikidata.org/wiki/Q18028978","display_name":"Mdm2","level":3,"score":0.623587965965271},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5129656195640564},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4369896650314331},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.42959973216056824},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.41429033875465393},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2939401865005493},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2872766852378845},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.17937704920768738},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004249","descriptor_name":"DNA Damage","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004273","descriptor_name":"DNA, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004273","descriptor_name":"DNA, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D004854","descriptor_name":"Herpesvirus 4, Human","qualifier_ui":"Q000472","qualifier_name":"pathogenicity","is_major_topic":false},{"descriptor_ui":"D004854","descriptor_name":"Herpesvirus 4, Human","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012514","descriptor_name":"Sarcoma, Kaposi","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D012514","descriptor_name":"Sarcoma, Kaposi","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D014183","descriptor_name":"Transplantation, Heterologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016158","descriptor_name":"Genes, p53","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D017735","descriptor_name":"Virus Latency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019288","descriptor_name":"Herpesvirus 8, Human","qualifier_ui":"Q000472","qualifier_name":"pathogenicity","is_major_topic":false},{"descriptor_ui":"D019288","descriptor_name":"Herpesvirus 8, Human","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1172/jci30945","doi":"https://doi.org/10.1172/jci30945","is_oa":true,"landing_page_url":"https://doi.org/10.1172/jci30945","pdf_url":"http://www.jci.org/articles/view/30945/files/pdf","source":{"id":"https://openalex.org/S114430552","display_name":"Journal of Clinical Investigation","issn_l":"0021-9738","issn":["0021-9738","1558-8238"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320279","host_organization_name":"American Society for Clinical Investigation","host_organization_lineage":["https://openalex.org/P4310320279"],"host_organization_lineage_names":["American Society for Clinical Investigation"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Investigation","raw_type":"journal-article"},{"id":"pmh:oai:pure.ed.ac.uk:openaire/22fdf7dc-48a4-442f-b5da-5c7a3dfe426f","doi":null,"is_oa":true,"landing_page_url":"https://www.research.ed.ac.uk/en/publications/22fdf7dc-48a4-442f-b5da-5c7a3dfe426f","pdf_url":"https://www.research.ed.ac.uk/files/8220914/Reactivation_of_the_p53_pathway_as_a_treatment_modality_for_KSHV_induced_lymphomas.pdf","source":{"id":"https://openalex.org/S4306400321","display_name":"Edinburgh Research Explorer (University of Edinburgh)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I98677209","host_organization_name":"University of Edinburgh","host_organization_lineage":["https://openalex.org/I98677209"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sarek, G, Kurki, S, Enback, J, Iotzova, G, Haas, J, Laakkonen, P, Laiho, M & Ojala, P M 2007, 'Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas', Journal of Clinical Investigation, vol. 117, no. 4, pp. 1019-1028. https://doi.org/10.1172/JCI30945","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1810577","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1810577/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Invest","raw_type":"Text"},{"id":"pmid:17364023","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17364023","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical investigation","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1172/jci30945","doi":"https://doi.org/10.1172/jci30945","is_oa":true,"landing_page_url":"https://doi.org/10.1172/jci30945","pdf_url":"http://www.jci.org/articles/view/30945/files/pdf","source":{"id":"https://openalex.org/S114430552","display_name":"Journal of Clinical Investigation","issn_l":"0021-9738","issn":["0021-9738","1558-8238"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320279","host_organization_name":"American Society for Clinical Investigation","host_organization_lineage":["https://openalex.org/P4310320279"],"host_organization_lineage_names":["American Society for Clinical Investigation"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Investigation","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G263710751","display_name":null,"funder_award_id":"2005-018704","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G7404019914","display_name":null,"funder_award_id":"LSHC-CT-2005-018704","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"}],"funders":[{"id":"https://openalex.org/F4320310086","display_name":"Helsingin Yliopisto","ror":"https://ror.org/040af2s02"},{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320321108","display_name":"Academy of Finland","ror":"https://ror.org/05k73zm37"},{"id":"https://openalex.org/F4320323807","display_name":"Institut National Du Cancer","ror":"https://ror.org/03m8vkq32"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2107942125.pdf","grobid_xml":"https://content.openalex.org/works/W2107942125.grobid-xml"},"referenced_works_count":53,"referenced_works":["https://openalex.org/W40653021","https://openalex.org/W1509901905","https://openalex.org/W1650797637","https://openalex.org/W1673837423","https://openalex.org/W1787380229","https://openalex.org/W1850446337","https://openalex.org/W1993263392","https://openalex.org/W1994711799","https://openalex.org/W1996767494","https://openalex.org/W2007249806","https://openalex.org/W2008887283","https://openalex.org/W2009714338","https://openalex.org/W2010734987","https://openalex.org/W2018228994","https://openalex.org/W2028318125","https://openalex.org/W2030086147","https://openalex.org/W2032438721","https://openalex.org/W2034853645","https://openalex.org/W2037548392","https://openalex.org/W2042316019","https://openalex.org/W2046083330","https://openalex.org/W2057718343","https://openalex.org/W2059971436","https://openalex.org/W2065642354","https://openalex.org/W2067444184","https://openalex.org/W2068889468","https://openalex.org/W2071580019","https://openalex.org/W2082559623","https://openalex.org/W2085622884","https://openalex.org/W2092462528","https://openalex.org/W2093872726","https://openalex.org/W2094584112","https://openalex.org/W2097933346","https://openalex.org/W2098641058","https://openalex.org/W2099904968","https://openalex.org/W2100494757","https://openalex.org/W2105155498","https://openalex.org/W2127423053","https://openalex.org/W2129377621","https://openalex.org/W2140125745","https://openalex.org/W2140325124","https://openalex.org/W2142107992","https://openalex.org/W2144326983","https://openalex.org/W2151858819","https://openalex.org/W2151911795","https://openalex.org/W2156730211","https://openalex.org/W2160508776","https://openalex.org/W2166589385","https://openalex.org/W2169669635","https://openalex.org/W2169977167","https://openalex.org/W2410723119","https://openalex.org/W2467833497","https://openalex.org/W4319292969"],"related_works":["https://openalex.org/W1990742762","https://openalex.org/W1567084078","https://openalex.org/W2059985804","https://openalex.org/W9956351","https://openalex.org/W2087010679","https://openalex.org/W2045395006","https://openalex.org/W2747080541","https://openalex.org/W2633601445","https://openalex.org/W3110918979","https://openalex.org/W2129377621"],"abstract_inverted_index":{"Kaposi's":[0,63],"sarcoma":[1],"herpesvirus":[2],"(KSHV)":[3],"is":[4],"the":[5,23,39,52,72,82,107,121,126,152,155],"etiologic":[6],"agent":[7],"for":[8,35,41,57,185,203],"primary":[9],"effusion":[10,20],"lymphoma":[11,16],"(PEL),":[12],"a":[13,32,37,175,196],"non-Hodgkin":[14],"type":[15],"manifesting":[17],"as":[18,31,190],"an":[19],"malignancy":[21],"in":[22,134,160,172,174],"affected":[24],"individual.":[25],"Although":[26],"KSHV":[27,108],"has":[28,49],"been":[29],"recognized":[30],"tumor":[33],"virus":[34],"over":[36],"decade,":[38],"pathways":[40],"its":[42],"tumorigenic":[43],"conversion":[44],"are":[45,66],"incompletely":[46],"understood,":[47],"which":[48],"greatly":[50],"hampered":[51],"development":[53],"of":[54,81,99,154,158,188],"efficient":[55],"therapies":[56,69],"KSHV-induced":[58,74],"malignancies":[59],"like":[60],"PEL":[61,100,135],"and":[62,95,117,119,129,198],"sarcoma.":[64],"There":[65],"no":[67],"current":[68],"effective":[70],"against":[71],"aggressive,":[73],"PEL.":[75],"Here":[76],"we":[77,164,192],"demonstrate":[78],"that":[79,106,120,142,166],"activation":[80,98],"p53":[83,116,189],"pathway":[84],"using":[85],"murine":[86],"double":[87],"minute":[88],"2":[89],"(MDM2)":[90],"inhibitor":[91,123],"Nutlin-3a":[92,124,159,167],"conveyed":[93],"specific":[94],"highly":[96,199],"potent":[97],"cell":[101],"killing.":[102],"Our":[103,179],"results":[104,140,180],"demonstrated":[105],"latency-associated":[109],"nuclear":[110],"antigen":[111],"(LANA)":[112],"bound":[113],"to":[114,151,194],"both":[115],"MDM2":[118,122],"disrupted":[125],"p53-MDM2-LANA":[127],"complex":[128],"selectively":[130],"induced":[131,206],"massive":[132],"apoptosis":[133],"cells.":[136,162],"Together":[137],"with":[138],"our":[139],"indicating":[141],"KSHV-infection":[143],"activated":[144],"DNA":[145],"damage":[146],"signaling,":[147],"these":[148],"findings":[149],"contribute":[150],"specificity":[153],"cytotoxic":[156],"effects":[157],"KSHV-infected":[161],"Moreover,":[163],"showed":[165],"had":[168],"striking":[169],"antitumor":[170],"activity":[171],"vivo":[173],"mouse":[176],"xenograft":[177],"model.":[178],"therefore":[181],"present":[182],"new":[183],"options":[184],"exploiting":[186],"reactivation":[187],"what":[191],"believe":[193],"be":[195],"novel":[197],"selective":[200],"treatment":[201],"modality":[202],"this":[204],"virally":[205],"lymphoma.":[207]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2107942125","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":24}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
